Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Trial Of BEAM Plus PBSCT Versus Single Agent High-Dose Therapy Followed By BEAM Plus PBSCT In Patients With Relapsed Hodgkin's Disease

NCT00025636 is registered in ClinicalTrials.gov with German Hodgkin's Lymphoma Study Group as lead sponsor.

NCT NCT00025636
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00025636 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Trial Of BEAM Plus PBSCT Versus Single Agent High-Dose Therapy Followed By BEAM Plus PBSCT In Patients With Relapsed Hodgkin's Disease
Lead sponsor
German Hodgkin's Lymphoma Study Group
Phase
Phase 3
Overall status
Unknown status
Start date
July 31, 2001
Completion date
Not reported
Enrollment
220 (estimated)
Sites
44

Conditions

As the registry lists them; a condition with its own page is linked.

lymphoma